6178 |
What are the Real-world Issue to Keep LDL-C Lower for Longer |
Seok-Jae Hwang |
Apr. 19. 24 |
6177 |
Consolidate PARTNER 3 5-year Data; More Information Available |
James Flaherty |
Apr. 19. 24 |
6176 |
New TAVI Trends Improve Lifetime Management |
Karl Poon |
Apr. 19. 24 |
6175 |
SAPIEN 3 Platform Handles Complex TAVI Cases |
Tae-Hyun Yang |
Apr. 19. 24 |
6174 |
How Can We Further Improve Reperfusion in AMI?: Revising or Novel Approach |
Adrian P. Banning |
Apr. 19. 24 |
6173 |
Thrombus Management in STEMI: What are Contemporary Thoughts in 2024? |
Sripal Bangalore |
Apr. 19. 24 |
6172 |
Strategic Sequencing: The Rationale Behind Staged Revascularization in ACS |
Youngkeun Ahn |
Apr. 19. 24 |
6171 |
Complete Revascularization for MVD STEMI Patient with Infarct-Related Cardiogenic Shock |
Chun Hung Su |
Apr. 19. 24 |
6170 |
Antithrombotic Therapy in ACS-PCI |
Dominick J. Angiolillo |
Apr. 19. 24 |
6169 |
Bifurcation Treatment in the Setting of CTO-PCI: Special Considerations |
Gerald Werner |
Apr. 19. 24 |